Cargando…

Quantitative evaluation of Kaiser score in diagnosing breast dynamic contrast-enhanced magnetic resonance imaging for patients with high-grade background parenchymal enhancement

BACKGROUND: High-grade background parenchymal enhancement (BPE), including moderate and marked, poses a considerable challenge for the diagnosis of breast disease due to its tendency to increase the rate of false positives and false negatives. The purpose of our study was to explore whether the Kais...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hui, Gao, Ling, Chen, Xu, Wang, Shou-Ju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585520/ https://www.ncbi.nlm.nih.gov/pubmed/37869283 http://dx.doi.org/10.21037/qims-23-113

Ejemplares similares

Quantitative assessment of background parenchymal enhancement in breast magnetic resonance images predicts the risk of breast cancer
por: Hu, Xiaoxin, et al.
Publicado: (2016)

Analysis of background parenchymal echogenicity on breast ultrasound: Correlation with mammographic breast density and background parenchymal enhancement on magnetic resonance imaging
por: Ko, Kyung Hee, et al.
Publicado: (2017)

Breast cancer and background parenchymal enhancement at breast magnetic resonance imaging: a meta-analysis
por: Hu, Na, et al.
Publicado: (2021)

Background parenchymal enhancement in contrast-enhanced MR imaging suggests systemic effects of intrauterine contraceptive devices
por: Huck, Luisa Charlotte, et al.
Publicado: (2022)

Background parenchymal enhancement in preoperative breast MRI
por: Kohara, Satoko, et al.
Publicado: (2015)

Ultrafast Dynamic Contrast-Enhanced Breast MRI: Lesion Conspicuity and Size Assessment according to Background Parenchymal Enhancement
por: Kim, Soo-Yeon, et al.
Publicado: (2020)

The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI
por: Hellgren, Roxanna, et al.
Publicado: (2020)

Quantitative background parenchymal enhancement to predict recurrence after neoadjuvant chemotherapy for breast cancer
por: Moliere, Sebastien, et al.
Publicado: (2019)

Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study
por: Yu, Liangliang, et al.
Publicado: (2020)

Quantitative analysis of permeability for glioma grading using dynamic contrast-enhanced magnetic resonance imaging
por: Zhao, Ming, et al.
Publicado: (2017)

MRI Texture Analysis of Background Parenchymal Enhancement of the Breast
por: Amano, Yasuo, et al.
Publicado: (2017)

MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2016)

Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status
por: Goodburn, Rosie, et al.
Publicado: (2023)

Background Parenchymal Enhancement on Contrast-Enhanced Spectral Mammography: Influence of Age, Breast Density, Menstruation Status, and Menstrual Cycle Timing
por: Zhao, Shuang, et al.
Publicado: (2020)

Differentiating Breast Tumors from Background Parenchymal Enhancement at Contrast-Enhanced Mammography: The Role of Radiomics—A Pilot Reader Study
por: Boca (Bene), Ioana, et al.
Publicado: (2021)

Correction: MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2016)

Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study
por: Wang, Jeff, et al.
Publicado: (2015)

Correction: Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status
por: Goodburn, Rosie, et al.
Publicado: (2023)

Background Parenchymal Enhancement on Preoperative Magnetic Resonance Imaging: Association With Recurrence-Free Survival in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
por: Choi, Ji Soo, et al.
Publicado: (2016)

Correlation Between Mammographic Breast Density, Breast Tissue Type in Ultrasonography, Fibroglandular Tissue, and Background Parenchymal Enhancement in Magnetic Resonance Imaging
por: Alikhassi, Afsaneh, et al.
Publicado: (2018)

The Role of Diffusion-Weighted Imaging Based on Maximum-Intensity Projection in Young Patients with Marked Background Parenchymal Enhancement on Contrast-Enhanced Breast MRI
por: Park, Ga-Eun, et al.
Publicado: (2023)

Background Parenchymal Enhancement on Breast MRI as a Prognostic Surrogate: Correlation With Breast Cancer Oncotype Dx Score
por: Zhang, Michelle, et al.
Publicado: (2021)

Magnetic resonance imaging of fibroadenoma-like lesions and correlation with Breast Imaging-Reporting and Data System and Kaiser scoring system
por: Cloete, Daniel J., et al.
Publicado: (2018)

The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams
por: Milos, Ruxandra Iulia, et al.
Publicado: (2020)

MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women
por: Brooks, Jennifer D., et al.
Publicado: (2018)

The Spectrum of Parenchymal Changes in Kidneys Affected by Intrarenal Reflux, Diagnosed by Contrast-Enhanced Voiding Urosonography and DMSA Scan
por: Simičić Majce, Ana, et al.
Publicado: (2022)

Quantitative imaging of tumour blood flow by contrast-enhanced magnetic resonance imaging
por: Pahernik, S, et al.
Publicado: (2001)

Quantitative evaluation of renal parenchymal perfusion using contrast-enhanced ultrasonography in renal ischemia-reperfusion injury in dogs
por: Lee, Gahyun, et al.
Publicado: (2017)

DCE-MRI Background Parenchymal Enhancement Quantified from an Early versus Delayed Post-contrast Sequence: Association with Breast Cancer Presence
por: Wu, Shandong, et al.
Publicado: (2017)

Harmonization of Quantitative Parenchymal Enhancement in T(1)‐Weighted Breast MRI
por: van der Velden, Bas H.M., et al.
Publicado: (2020)

Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study
por: Watt, Gordon P., et al.
Publicado: (2020)

Fibroglandular Tissue and Background Parenchymal Enhancement on Breast MR Imaging Correlates With Breast Cancer
por: Hu, Xiaoxin, et al.
Publicado: (2021)

Kaiser Guillermo II
por: Wilson, Lawrence Patrick Roy
Publicado: (1967)

Contrast agents in dynamic contrast-enhanced magnetic resonance imaging
por: Yan, Yuling, et al.
Publicado: (2017)

Utility of diffusion-weighted and contrast-enhanced magnetic resonance imaging in diagnosing and differentiating between high- and low-grade uterine endometrial stromal sarcoma
por: Huang, Yen-Ling, et al.
Publicado: (2019)

Diagnostic performance of contrast-enhanced ultrasound and enhanced magnetic resonance for breast nodules
por: Li, Cuiying, et al.
Publicado: (2018)

Background enhancement in contrast-enhanced spectral mammography (CESM): are there qualitative and quantitative differences between imaging systems?
por: Wessling, Daniel, et al.
Publicado: (2022)

Post-Processing Bias Field Inhomogeneity Correction for Assessing Background Parenchymal Enhancement on Breast MRI as a Quantitative Marker of Treatment Response
por: Nguyen, Alex Anh-Tu, et al.
Publicado: (2022)

Prediction of background parenchymal enhancement on breast MRI using mammography, ultrasonography, and diffusion-weighted imaging
por: Kawamura, Akiko, et al.
Publicado: (2015)

The Assessment of Background Parenchymal Enhancement (BPE) in a High-Risk Population: What Causes BPE?
por: You, Chao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9df8uf0frbhp20hmpvqrb31n0m